KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Amortizatization of Intangibles (2023 - 2025)

Biogen (BIIB) has 3 years of Amortizatization of Intangibles data on record, last reported at $75.4 million in Q4 2025.

  • For Q4 2025, Amortizatization of Intangibles rose 67.93% year-over-year to $75.4 million; the TTM value through Dec 2025 reached $240.8 million, up 4.7%, while the annual FY2025 figure was $240.8 million, 4.7% up from the prior year.
  • Amortizatization of Intangibles reached $75.4 million in Q4 2025 per BIIB's latest filing, up from $61.5 million in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $90.1 million in Q2 2024 and bottomed at $31.5 million in Q4 2023.
  • Average Amortizatization of Intangibles over 3 years is $55.8 million, with a median of $51.4 million recorded in 2025.
  • The widest YoY moves for Amortizatization of Intangibles: up 67.93% in 2025, down 41.73% in 2025.
  • A 3-year view of Amortizatization of Intangibles shows it stood at $31.5 million in 2023, then skyrocketed by 42.54% to $44.9 million in 2024, then surged by 67.93% to $75.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Amortizatization of Intangibles were $75.4 million in Q4 2025, $61.5 million in Q3 2025, and $52.5 million in Q2 2025.